LipimetiX Development is a company that provides Medicine, Pharmacy and Therapeutics, Orphan drug and more. LipimetiX Development is headquartered in United States Massachusetts. LipimetiX Development was founded in 2012. and was founded by Dennis I. Goldberg, Eric Morrel. LipimetiX Development has a total of 25 patents
visualizing technology portfolio of hot application areas and blank areas for LipimetiX Development
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for LipimetiX Development
Sign up to view the full data
Free Trial Now
Download
Top Related Companies
Sign up to view the full data
Free Trial Now
LipimetiX Development Frequently Asked Questions
What is LipimetiX Development's industry?
LipimetiX Development is in the industry of:Pharmaceutical and Medicine Manufacturing
What technical fields has LipimetiX Development researched?
LipimetiX Development has researched the technical fields related toMedicinePharmacy and TherapeuticsOrphan drugCardiovascular agentClinical trialCholesterolDrug developmentDrug discoveryAcute pancreatitisHypertriglyceridemiaTriglycerideArteryPeptideApolipoprotein ELipoproteinArtery diseasesReceptorInflammationGastrointestinal agentBiopharmaceutical
What is LipimetiX Development's total number of patents?
LipimetiX Development was established as a joint venture between Capstone Therapeutics Corp. (OTCQB: CAPS), and LipimetiX, Inc.
We are a privately held...